Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications
BCL11B targeting in tumor CD8 + T cells amplifies anti-tumor response by blocking exhaustion while promoting stemness and cytotoxicity.
Journal: bioRxiv : the preprint server for biology
Published: August 15, 2026
Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanoma.
Journal: Med (New York, N.Y.)
Published: March 17, 2026
Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial.
Journal: Journal for immunotherapy of cancer
Published: December 16, 2025
ASO Visual Abstract: Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative or Not Performed Sentinel Lymph Node Biopsy.
Journal: Annals of surgical oncology
Published: December 08, 2025
Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small lymphocytic lymphoma.
Journal: Frontiers in immunology
Published: October 03, 2025
Safety and Efficacy of Tumor-Infiltrating Lymphocyte Therapy with Reduced-Dose Lymphodepleting Conditioning in High-Risk Metastatic Melanoma Patients.
Journal: Transplantation and cellular therapy
Published: September 04, 2025
Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative, or Not Performed Sentinel Lymph Node Biopsy.
Journal: Annals of surgical oncology
Published: June 25, 2025
Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 02, 2025
Role of high-dose interleukin-2 for melanoma in the age of cellular therapy.
Journal: Journal for immunotherapy of cancer
Published: May 06, 2025
CD40L stimulates tumor-infiltrating B-cells and improves ex vivo TIL expansion.
Journal: Journal for immunotherapy of cancer
Published: March 24, 2025
The Use of Radar-Guided Localization to Identify Metastatic Melanoma After Neoadjuvant Immunotherapy.
Journal: Annals of surgical oncology
Published: February 07, 2025
Lifileucel tumor-infiltrating lymphocyte cell therapy in patients with unresectable or metastatic mucosal melanoma after disease progression on immune checkpoint inhibitors.
Journal: Cancer communications (London, England)
Published: January 24, 2025
Last Updated: 09/26/2026